M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) Short Interest Update

M3-Brigade Acquisition V Corp. (NASDAQ:MBAVGet Free Report) was the recipient of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 131,764 shares, a growth of 304.4% from the February 12th total of 32,579 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 24,712 shares, the days-to-cover ratio is currently 5.3 days. Based on an average daily volume of 24,712 shares, the days-to-cover ratio is currently 5.3 days. Currently, 0.4% of the company’s stock are short sold.

Insider Activity

In other news, major shareholder Fitzgerald & Co. Cantor bought 3,529,081 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The stock was acquired at an average cost of $10.80 per share, with a total value of $38,114,074.80. Following the completion of the purchase, the insider owned 7,779,865 shares of the company’s stock, valued at $84,022,542. This represents a 83.02% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Hedge Funds Weigh In On M3-Brigade Acquisition V

Institutional investors have recently made changes to their positions in the stock. Saba Capital Management L.P. bought a new position in M3-Brigade Acquisition V in the fourth quarter worth approximately $151,000. Hudson Bay Capital Management LP bought a new stake in shares of M3-Brigade Acquisition V in the 4th quarter worth approximately $159,000. Prelude Capital Management LLC bought a new stake in shares of M3-Brigade Acquisition V in the 3rd quarter worth approximately $281,000. Sandia Investment Management LP purchased a new position in M3-Brigade Acquisition V in the second quarter valued at approximately $334,000. Finally, Clear Street LLC grew its holdings in M3-Brigade Acquisition V by 2,280.8% during the second quarter. Clear Street LLC now owns 32,069 shares of the company’s stock valued at $362,000 after purchasing an additional 30,722 shares during the period.

M3-Brigade Acquisition V Stock Up 0.0%

Shares of NASDAQ:MBAV traded up $0.00 during trading on Wednesday, hitting $10.70. 10,970 shares of the company were exchanged, compared to its average volume of 127,102. The business’s 50 day moving average is $10.67 and its 200-day moving average is $10.62. M3-Brigade Acquisition V has a 1-year low of $10.17 and a 1-year high of $13.73.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Get Our Latest Stock Report on MBAV

About M3-Brigade Acquisition V

(Get Free Report)

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.

Featured Articles

Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.